Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)

NCT00358228 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
787
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi